This Analyst Says Orthopedic-Focused Orthofix Medical Is Positioned For Growth
Canaccord Genuity initiates coverage on Orthofix Medical with a Buy rating and $24 price target, citing growth potential and strong financial outlook. Latest Ratings for OFIX Date Firm Action From To Mar 2022 Stifel Upgrades Hold Buy Oct 2020 Stifel Initiates Coverage On Hold Feb 2020 Sidoti & Co. Maintains Buy View More Analyst Ratings…